Rejuversen

𝑺𝒕𝒆𝒑 𝒊𝒏𝒕𝒐 𝒕𝒉𝒆 𝒘𝒐𝒓𝒍𝒅 𝒐𝒇 𝒄𝒖𝒕𝒕𝒊𝒏𝒈-𝒆𝒅𝒈𝒆 𝒑𝒉𝒂𝒓𝒎𝒂𝒄𝒆𝒖𝒕𝒊𝒄𝒂𝒍 𝒊𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏 at the 24th Drug Discovery Innovation Programme, 𝒘𝒉𝒆𝒓𝒆 𝒘𝒆 𝒑𝒓𝒐𝒖𝒅𝒍𝒚 𝒑𝒓𝒆𝒔𝒆𝒏𝒕 𝒂𝒏 𝒆𝒙𝒄𝒆𝒑𝒕𝒊𝒐𝒏𝒂𝒍 𝒍𝒊𝒏𝒆𝒖𝒑 𝒐𝒇 𝒈𝒖𝒆𝒔𝒕 𝒔𝒑𝒆𝒂𝒌𝒆𝒓𝒔 𝒂𝒏𝒅 𝒅𝒊𝒔𝒕𝒊𝒏𝒈𝒖𝒊𝒔𝒉𝒆𝒅 𝒔𝒑𝒐𝒏𝒔𝒐𝒓𝒔. Each speaker brings profound insights and expertise, guiding us through the latest advancements and future trends in drug discovery. Our sponsors, renowned leaders in the industry, stand alongside us in advancing healthcare through their invaluable support and collaboration. 𝑱𝒐𝒊𝒏 𝒖𝒔 𝒇𝒐𝒓 𝒂𝒏 𝒊𝒏𝒔𝒑𝒊𝒓𝒊𝒏𝒈 𝒈𝒂𝒕𝒉𝒆𝒓𝒊𝒏𝒈 𝒘𝒉𝒆𝒓𝒆 𝒌𝒏𝒐𝒘𝒍𝒆𝒅𝒈𝒆 𝒎𝒆𝒆𝒕𝒔 𝒐𝒑𝒑𝒐𝒓𝒕𝒖𝒏𝒊𝒕𝒚, 𝒔𝒉𝒂𝒑𝒊𝒏𝒈 𝒕𝒉𝒆 𝒇𝒖𝒕𝒖𝒓𝒆 𝒐𝒇 𝒎𝒆𝒅𝒊𝒄𝒊𝒏𝒆 𝒕𝒐𝒈𝒆𝒕𝒉𝒆𝒓. #leadership #drugdiscovery #innovation #genomics #sciencestudent #steam #scientist #biologics #medicinalchem #drugdiscovery #oncology #drugdiscoveryconference #ddipeu #worldbievents #scienceresearch #ddip24 Soroush Safaei | Sanofi | Gabriele Magaro' | Rudi Schmidt | Institute for Healthier Living Abu Dhabi | Claude Bertrand | Servier | Johan Luthman | Lundbeck | Davide Gianni | AstraZeneca | Claudio Hidalgo Cantabrana | Microviable Therapeutics SL | Alex Alderton | Dr. Rafik FELLAGUE-CHEBRA, MD, MSc | Novartis Oncology | DAVID MORENO DELGADO | Galapagos | Juan Basterra | Mikrobiomik | Konstantinos Gkatzis, PhD | Ksilink | Jekaterina Kaliniene, EMBA | Innovation Agency Lithuania | Global | Maria Loustau | Invectys | Neelima Khairatkar-Joshi | Eric Scheinbart M.D. | Dr. Devendra Ridhurkar | Fred Manby | Iambic Therapeutics | Timothy Cash | Rejuversen

📍 The Catalan delegation at #BIO2024 in San Diego will include 37 companies and entities from the #biotechnology sector based in Catalonia, representing more than 40% of the Spanish delegation. Come and meet them! You will find some of these companies at the Spain Pavilion #3424 (coordinated by ICEX) or at the #1511 Europe Pavilion alongside with other European biotechnology companies, academic institutions and stakeholders. Are you willing to know further the biotechnology ecosystems in the US and Catalonia❓ ⏰ Join the Catalonia BioNetworking Event on June 3, from 6:00 pm to 7:30 pm. A side event (organized by The Government of Catalonia, ACCIÓ, and #Biocat) for companies and organizations willing to create synergies, share knowledge, and better understand the #biotechnology ecosystems of North America and #Catalonia. Sign up! 👉 https://tuit.cat/c925S

Exciting times for senotherapeutics!

Foundational studies that led to development of Rejuveron Senescence Therapeutics lead, late-preclinical stage, therapeutic asset RST-001 now published in Nature Cancer! Congratulations to Selim Chaib, José Alberto López-Domínguez and RST co-founder Manuel Serrano for this fine body of work that has translated into the development of a promising therapy! https://lnkd.in/desicfrQ

We are hiring a Bioinformatic Scientist! Please send your CV to tim@rejuveron.com if you are interested in joining Rejuveron Senescence Therapeutics a dynamic biotech startup company!

Proud member of CataloniaBio & HealthTech ! Thank you to Roser Montserrat Alavedra and Javier Selva for supporting the creation of this video to introduce us to the community! https://lnkd.in/dGGWixSB